Hydroxycarbamide
Pharmaceutical forms
Solid oral dosage form
Country lists
ATC N/A
Composition 200 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
8.2. Cytotoxic and adjuvant medicines
  • No observations
WHO Model List of Essential Medicines
10.3. Other medicines for haemoglobinopathies
  • No observations
Solid oral dosage form
Country lists
ATC N/A
Composition 250 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
8.2. Cytotoxic and adjuvant medicines
  • No observations
Solid oral dosage form
Country lists
ATC N/A
Composition 300 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
8.2. Cytotoxic and adjuvant medicines
  • No observations
Solid oral dosage form
Country lists
ATC N/A
Composition 400 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
8.2. Cytotoxic and adjuvant medicines
  • No observations
Solid oral dosage form
Country lists
ATC N/A
Composition 500 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
8.2. Cytotoxic and adjuvant medicines
  • No observations
WHO Model List of Essential Medicines
10.3. Other medicines for haemoglobinopathies
  • No observations
Peru
8.2 Cytotoxics
  • No observations
Solid oral dosage form
Country lists
ATC N/A
Composition 1 g
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
8.2. Cytotoxic and adjuvant medicines
  • No observations
WHO Model List of Essential Medicines
10.3. Other medicines for haemoglobinopathies
  • No observations